- Home
- AAME vs INKT Comparison
AAME vs INKT Comparison
Compare AAME & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAME
- INKT
- Stock Information
- Founded
- AAME 1968
- INKT 2017
- Country
- AAME United States
- INKT United States
- Employees
- AAME N/A
- INKT N/A
- Industry
- AAME Life Insurance
- INKT Medicinal Chemicals and Botanical Products
- Sector
- AAME Finance
- INKT Health Care
- Exchange
- AAME Nasdaq
- INKT Nasdaq
- Market Cap
- AAME 35.9M
- INKT 28.9M
- IPO Year
- AAME N/A
- INKT 2021
- Fundamental
- Price
- AAME $2.08
- INKT $7.39
- Analyst Decision
- AAME
- INKT Strong Buy
- Analyst Count
- AAME 0
- INKT 2
- Target Price
- AAME N/A
- INKT $37.50
- AVG Volume (30 Days)
- AAME 7.9K
- INKT 15.0K
- Earning Date
- AAME 08-13-2025
- INKT 08-12-2025
- Dividend Yield
- AAME 0.98%
- INKT N/A
- EPS Growth
- AAME N/A
- INKT N/A
- EPS
- AAME N/A
- INKT N/A
- Revenue
- AAME $191,355,000.00
- INKT N/A
- Revenue This Year
- AAME N/A
- INKT N/A
- Revenue Next Year
- AAME N/A
- INKT N/A
- P/E Ratio
- AAME N/A
- INKT N/A
- Revenue Growth
- AAME 2.04
- INKT N/A
- 52 Week Low
- AAME $1.25
- INKT $4.56
- 52 Week High
- AAME $2.22
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- AAME 68.83
- INKT 50.22
- Support Level
- AAME $1.73
- INKT $6.98
- Resistance Level
- AAME $2.22
- INKT $8.38
- Average True Range (ATR)
- AAME 0.13
- INKT 0.30
- MACD
- AAME 0.02
- INKT -0.00
- Stochastic Oscillator
- AAME 65.45
- INKT 32.41
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.